Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAMPT | P43490 | 9/20 | 0.49 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.48 |
| ▸ | ITGAV | P06756 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7790196 | 0.92 | HTT (0.47) | NAMPTITGB3ITGAV | |
| SCHEMBL7785608 | 0.81 | NAMPT (0.57) | NAMPTITGB3ITGAVSMN1; SMN2L3MBTL1 | |
| SCHEMBL7790192 | 0.73 | NAMPT (0.58) | NAMPTITGB3ITGAV | |
| SCHEMBL11614852 | 0.71 | SMN1; SMN2 (0.81) | NAMPTSMN1; SMN2L3MBTL1NPC1LMNA | |
| SCHEMBL7143516 | 0.70 | CYP3A4 (0.54) | NAMPTSMN1; SMN2LMNATSHRCYP3A4 | |
| Ammonia Solution, Strong SCHEMBL29131270 | 0.70 | SMN1; SMN2 (0.79) | NAMPTSMN1; SMN2L3MBTL1NPC1LMNA | |
| SCHEMBL4955915 | 0.69 | ITGB3 (0.43) | ITGB3ITGAV | |
| SCHEMBL7370194 | 0.69 | TSHR (0.58) | NAMPTITGB3ITGAVSMN1; SMN2L3MBTL1 | |
| SCHEMBL6156731 | 0.69 | CASP1 (0.60) | — | |
| SCHEMBL6955527 | 0.69 | CASP1 (0.60) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1147079-A2 | BETA-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS | Bayer Aktiengesellschaft (DE) | 2001-10-24 | — | — | EP | disclosed |
| WO-2000041469-A2 | β-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS | BAYER AKTIENGESELLSCHAFT (DE) | 2000-07-20 | — | — | WO | disclosed |